PPSG
BIOL

Princeton Portfolio Strategies Group’s Biolase, Inc. BIOL Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1
Closed -$31K – 124
2014
Q1 		$31K Hold
1
– – 0.02% 108
2013
Q4 		$38K Sell
1
-10
-91% -$237K 0.03% 110
2013
Q3 		$262K Buy
11
+3
+38% +$96.6K 0.19% 95
2013
Q2 		$346K Buy
+8
New +$447K 0.28% 83

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Princeton Portfolio Strategies Group's BIOL Position: Q2 2014 in Review

Princeton Portfolio Strategies Group sold out of Biolase, Inc. (BIOL) in Q2 2014, closing a stake of 1 share — an estimated $31K sold.

Princeton Portfolio Strategies Group first reported a position in BIOL in Q2 2013 and held it in 4 quarters. The position peaked at $346K in Q2 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q2 2014.

  • Princeton Portfolio Strategies Group reported no remaining Biolase, Inc. position as of Q2 2014 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 1 Biolase, Inc. share in Q2 2014, an estimated $31K.
  • Princeton Portfolio Strategies Group first reported a position in Biolase, Inc. in Q2 2013 and held it in 4 quarters.
  • Princeton Portfolio Strategies Group's Biolase, Inc. position peaked at $346K in Q2 2013.
  • 34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2014.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2014, filed 15 Aug 2014.